Can pharma tariffs “Make America Manufacture Again”?
Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.
BioNTech to invest up to $1.34bn in UK R&D
FDA to restrict Covid-19 booster doses to older adults
Pfizer signs global licensing deal with 3SBio for bispecific antibody
Countries formally adopt WHO’s Pandemic Agreement for future pandemics
Regeneron buys bankrupt 23andMe for $256m
Analysis
View More
Themes
View MorePharma’s AI prospects get nudged into the future with EU’s AI act
Experts predict growing pains as the life sciences sector moves to adapt to the EU AI Act.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Next-generation targeting for evolving HCP engagement
Are regulators keeping pace with AI adoption in clinical trials?
Recursion axes drug programmes to streamline pipeline
AstraZeneca enters $200m AI cancer pact with Tempus and Pathos